Hans Petter Eikesdal

1972 - 2023

country of citizenship: Norway

educated at: University of Bergen

occupation: researcher, oncologist, professor

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 32

Date

Title

Authors

2022-10-15

PARP-inhibition reprograms macrophages toward an anti-tumor phenotype

Gerburg M Wulf, Hans Petter Eikesdal
2020-04-01

Correction to: Semi-automatic segmentation from intrinsically-registered 18F-FDG-PET/MRI for treatment response assessment in a breast cancer cohort: comparison to manual DCE-MRI

Neil P Jerome, Hans Petter Eikesdal
2020-04-21

An Ultrasensitive Routine LC-MS/MS Method for Estradiol and Estrone in the Clinically Relevant Sub-Picomolar Range

Ralf Kellmann, Hans Petter Eikesdal, Per Eystein Lønning, Jørn V Sagen, Bjørg Almås
2019-09-27

Semi-automatic segmentation from intrinsically-registered 18F-FDG-PET/MRI for treatment response assessment in a breast cancer cohort: comparison to manual DCE-MRI

Neil P Jerome, Hans Petter Eikesdal
2019-02-23

Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

Hans Petter Eikesdal
2019-03-22

Constitutional Mosaic Epimutations - a hidden cause of cancer?

Per Eystein Lønning, Stian Knappskog, Hans Petter Eikesdal
2018-06-22

BMP7 Signaling in TGFBR2-Deficient Stromal Cells Provokes Epithelial Carcinogenesis

Lisa Becker, Julienne L. Carstens, Hans Petter Eikesdal
2017-04-17

Activation of Akt characterizes estrogen receptor positive human breast cancers which respond to anthracyclines

Per Eystein Lønning, Stian Knappskog, Hans Petter Eikesdal
2017-02-17

High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function

Per Eystein Lønning, Stian Knappskog, Peer Lilleng, Hans Petter Eikesdal
2017-10-11

Divergent Activity of the Pseudogene PTENP1 in ER-Positive and Negative Breast Cancer.

Per Eystein Lønning, Hans Petter Eikesdal
2016-08-15

Lymphatic vessels regulate immune microenvironments in human and murine melanoma

Amanda W. Lund, Manuel Fankhauser, Maria A Broggi, Kari Alitalo, Helge Wiig, Thomas F Gajewski, Hans Petter Eikesdal
2016-12-22

Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapy

Per Eystein Lønning, Funda Meric-Bernstam, Hans Petter Eikesdal
2016-06-13

Impaired lymphatic function accelerates cancer growth

Helge Wiig, Hans Petter Eikesdal
2015-09-09

BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study

Bjørn Ivar Haukanes, Nicoline Hoogerbrugge, Vidar M Steen, Hans Petter Eikesdal
2014-06-09

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy

Per Eystein Lønning, Stian Knappskog, Turid Aas, Hans Petter Eikesdal
2014-02-28

The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy

Per Eystein Lønning, Hans Petter Eikesdal
2014-08-19

[Dental health when using bisphosphonates against breast cancer]

Hans Petter Eikesdal
2013-06-24

Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved

Per Eystein Lønning, Hans Petter Eikesdal
2012

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

Per Eystein Lønning, Anders Molven, Lars A. Akslen, Stephanie Geisler, Hans Petter Eikesdal
2012-11-02

Tumor vasculature: the Achilles' heel of cancer?

Rolf Bjerkvig, Hans Petter Eikesdal
2012-12-17

Lethal pneumonitis after docetaxel chemotherapy: case report and review of the literature

Hans Petter Eikesdal
2009-06-11

Drug resistance associated with antiangiogenesis therapy

Raghu Kalluri, Hans Petter Eikesdal
2008-09-25

Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity

Gabriel Birrane, Mark W. Kieran, Raghu Kalluri, Hans Petter Eikesdal
2008-05-21

A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions

Simone P Niclou, Helge Wiig, Anja Torsvik, Rolf Bjerkvig, Per Øyvind Enger, Agnete Svendsen, Nicolaas H C Brons, Hans Petter Eikesdal
2004-08-01

[Tumour angiogenesis and therapy directed at the neovasculature]

Oddbjørn Straume, Olav Dahl, Lars A. Akslen, Hans Petter Eikesdal
2003-03-01

Oxygenation and response to irradiation of organotypic multicellular spheroids of human glioma

Berend J Slotman, Rolf Bjerkvig, Hans Petter Eikesdal
2002-04-01

The influence of combretastatin A-4 and vinblastine on interstitial fluid pressure in BT4An rat gliomas

Olav Dahl, Hans Petter Eikesdal
2002-03-01

Hyperthermia exhibits anti-vascular activity in the s.c. BT4An rat glioma: lack of interaction with the angiogenesis inhibitor batimastat

Olav Dahl, Hans Petter Eikesdal
2001-08-01

Combretastatin A-4 and hyperthermia;a potent combination for the treatment of solid tumors

Olav Mella, Olav Dahl, Rolf Bjerkvig, Hans Petter Eikesdal
2001-12-01

Tumor vasculature is targeted by the combination of combretastatin A-4 and hyperthermia

Olav Mella, Olav Dahl, Rolf Bjerkvig, Hans Petter Eikesdal
2001-10-01

Vinblastine and hyperthermia target the neovasculature in BT(4)AN rat gliomas: therapeutic implications of the vascular phenotype.

Olav Dahl, Rolf Bjerkvig, Hans Petter Eikesdal
2000-02-01

The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma.

Olav Mella, Olav Dahl, Hans Petter Eikesdal

Human - wd:Q96155943

Welcome to Inventaire

the library of your friends and communities

learn more